Bluebird Bio reported $832.32M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amgen AMGN:US $ 24380M 5281M
Applied Genetic Technologies AGTC:US $ 93.39M 16.32M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Avrobio Inc AVRO:US 211.66M 21.86M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Gilead Sciences GILD:US $ 14200M 275M
Immunogen IMGN:US $ 296.8M 22.41M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Novartis NOVN:VX 26.25B 2.45B
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
YTE INCY:US $ 2923.8M 303.74M